The successful development of several coronavirus disease 2019 (COVID-19) vaccines has
substantially reduced morbidity and mortality in regions of the world where the vaccines …

SARS-CoV-2 mRNA vaccines confer robust protection against COVID-19, but the emergence
of variants has generated concerns regarding the protective efficacy of the currently …

The introduction of vaccines has inspired hope in the battle against SARS-CoV-2. However,
the emergence of viral variants, in the absence of potent antivirals, has left the world …

Humoral responses in coronavirus disease 2019 (COVID-19) are often of limited durability,
as seen with other human coronavirus epidemics. To address the underlying etiology, we …

Although children have been largely spared from coronavirus disease 2019 (COVID-19), the
emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of …

Alphaviruses are emerging, mosquito-transmitted pathogens that cause musculoskeletal
and neurological disease in humans. Although neutralizing antibodies that inhibit individual …

Despite the success of COVID-19 vaccines, severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) variants of concern have emerged that can cause breakthrough infections. …

Janus emulsion assays that rely on carbohydrate–lectin binding for the detection of Escherichia
coli bacteria are described. Surfactants containing mannose are self-assembled at the …

Mechanisms of neutrophil involvement in severe coronavirus disease 2019 (COVID-19)
remain incompletely understood. Here, we collect longitudinal blood samples from 306 …

Glycoconjugate vaccines based on capsular polysaccharides (CPSs) of pathogenic bacteria
such as Streptococcus pneumoniae successfully protect from disease but suffer from …